BSE Live
Dec 24, 16:01Prev. Close
412.85
Open Price
410.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 24, 15:59Prev. Close
412.35
Open Price
410.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
422.00 (10)
| Key Financial Ratios of Aarti Drugs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 58.12 | 37.42 | 30.67 | 30.84 | 27.37 | |
| Diluted EPS (Rs.) | 58.12 | 37.42 | 30.67 | 30.84 | 27.37 | |
| Cash EPS (Rs.) | 78.26 | 54.13 | 47.16 | 47.02 | 42.07 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 266.86 | 219.90 | 183.69 | 162.20 | 144.66 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 266.86 | 219.90 | 183.69 | 162.20 | 144.66 | |
| Dividend / Share(Rs.) | 2.00 | 1.00 | 1.00 | 1.00 | 6.75 | |
| Revenue from Operations/Share (Rs.) | 701.68 | 616.68 | 483.61 | 456.35 | 444.11 | |
| PBDIT/Share (Rs.) | 105.35 | 85.58 | 77.61 | 75.01 | 70.90 | |
| PBIT/Share (Rs.) | 85.32 | 68.45 | 61.58 | 59.63 | 56.21 | |
| PBT/Share (Rs.) | 75.10 | 54.12 | 47.58 | 45.18 | 38.33 | |
| Net Profit/Share (Rs.) | 58.23 | 37.00 | 31.13 | 31.64 | 27.37 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 15.01 | 13.87 | 16.04 | 16.43 | 15.96 | |
| PBIT Margin (%) | 12.15 | 11.09 | 12.73 | 13.06 | 12.65 | |
| PBT Margin (%) | 10.70 | 8.77 | 9.83 | 9.89 | 8.63 | |
| Net Profit Margin (%) | 8.29 | 6.00 | 6.43 | 6.93 | 6.16 | |
| Return on Networth / Equity (%) | 21.82 | 16.82 | 16.94 | 19.50 | 18.92 | |
| Return on Capital Employed (%) | 21.73 | 19.55 | 19.96 | 21.33 | 11.47 | |
| Return on Assets (%) | 9.22 | 6.35 | 5.57 | 6.76 | 6.28 | |
| Total Debt/Equity (X) | 0.53 | 0.85 | 1.11 | 1.08 | 1.23 | |
| Asset Turnover Ratio (%) | 111.16 | 105.92 | 86.64 | 97.54 | 101.97 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.48 | 1.34 | 1.18 | 1.18 | 1.14 | |
| Quick Ratio (X) | 0.93 | 0.93 | 0.75 | 0.76 | 0.79 | |
| Inventory Turnover Ratio (X) | 5.32 | 6.39 | 4.49 | 5.77 | 6.44 | |
| Dividend Payout Ratio (NP) (%) | 5.15 | 2.70 | 3.24 | 0.00 | 24.66 | |
| Dividend Payout Ratio (CP) (%) | 3.83 | 1.84 | 2.14 | 0.00 | 16.04 | |
| Earnings Retention Ratio (%) | 94.85 | 97.30 | 96.76 | 0.00 | 75.34 | |
| Cash Earnings Retention Ratio (%) | 96.17 | 98.16 | 97.86 | 0.00 | 83.96 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,505.56 | 1,947.07 | 1,673.27 | 1,786.12 | 1,528.75 | |
| EV/Net Operating Revenue (X) | 0.92 | 1.34 | 1.47 | 1.64 | 1.42 | |
| EV/EBITDA (X) | 6.13 | 9.65 | 9.14 | 9.98 | 8.90 | |
| MarketCap/Net Operating Revenue (X) | 0.72 | 1.04 | 1.05 | 1.26 | 1.02 | |
| Retention Ratios (%) | 94.84 | 97.29 | 96.75 | 0.00 | 75.33 | |
| Price/BV (X) | 1.90 | 2.91 | 2.76 | 3.55 | 3.14 | |
| Price/Net Operating Revenue | 0.72 | 1.04 | 1.05 | 1.26 | 1.02 | |
| Earnings Yield | 0.12 | 0.06 | 0.06 | 0.05 | 0.06 |
14.11.2025
Aarti Drugs Consolidated September 2025 Net Sales at Rs 652.79 crore, up 9.1% Y-o-Y
12.11.2025
Aarti Drugs Standalone September 2025 Net Sales at Rs 578.95 crore, up 6.6% Y-o-Y
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y